157 related articles for article (PubMed ID: 15499286)
21. The aftermath of orbital radiotherapy for graves' ophthalmopathy.
Gorman CA; Garrity JA; Fatourechi V; Bahn RS; Petersen IA; Stafford SL; Earle JD; Forbes GS; Kline RW; Buettner H; Robertson DM; Bergstralh EJ; Offord KP; Rademacher DM; Stanley NM; Bartley GB
Ophthalmology; 2002 Nov; 109(11):2100-7. PubMed ID: 12414422
[TBL] [Abstract][Full Text] [Related]
22. Therapy of Graves' ophthalmopathy with intravenous high-dose steroid followed by orbital irradiation.
Koshiyama H; Koh T; Fujiwara K; Hayakawa K; Shimbo S; Misaki T
Thyroid; 1994; 4(4):409-13. PubMed ID: 7711503
[TBL] [Abstract][Full Text] [Related]
23. Letter: Orbital radiation in Graves' disease.
Rubenzik R
Am J Ophthalmol; 1975 May; 79(5):888-9. PubMed ID: 1173740
[No Abstract] [Full Text] [Related]
24. Prognostic factors in the radiotherapy of Graves' ophthalmopathy.
Petersen IA; Kriss JP; McDougall IR; Donaldson SS
Int J Radiat Oncol Biol Phys; 1990 Aug; 19(2):259-64. PubMed ID: 2118493
[TBL] [Abstract][Full Text] [Related]
25. Orbital cobalt irradiation combined with retrobulbar or systemic corticosteroids for Graves' ophthalmopathy: a comparative study.
Marcocci C; Bartalena L; Panicucci M; Marconcini C; Cartei F; Cavallacci G; Laddaga M; Campobasso G; Baschieri L; Pinchera A
Clin Endocrinol (Oxf); 1987 Jul; 27(1):33-42. PubMed ID: 3308192
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves' ophthalmopathy: results of a prospective, single-blind, randomized study.
Marcocci C; Bartalena L; Tanda ML; Manetti L; Dell'Unto E; Rocchi R; Barbesino G; Mazzi B; Bartolomei MP; Lepri P; Cartei F; Nardi M; Pinchera A
J Clin Endocrinol Metab; 2001 Aug; 86(8):3562-7. PubMed ID: 11502779
[TBL] [Abstract][Full Text] [Related]
27. The use of orbital radiotherapy for Graves' ophthalmopathy: quantitative review of the evidence.
Wei RL; Cheng JW; Cai JP
Ophthalmologica; 2008; 222(1):27-31. PubMed ID: 18097177
[TBL] [Abstract][Full Text] [Related]
28. [Treatment of Grave's ophthalmopathy with high doses of corticosteroids].
Cirić J; Zarković M; Stojanović M; Pepenezić Z; Randjelović G; Gligorović M; Trbojević B; Drezgić M; Nesović M
Srp Arh Celok Lek; 2000; 128(5-6):179-83. PubMed ID: 11089418
[TBL] [Abstract][Full Text] [Related]
29. Assessment of a carcinogenic risk for treatment of Graves' ophthalmopathy in dependence on age and irradiation geometry.
Broerse JJ; Snijders-Keilholz A; Jansen JT; Zoetelief J; Klein C; Seegenschmiedt MH
Radiother Oncol; 1999 Dec; 53(3):205-8. PubMed ID: 10660199
[TBL] [Abstract][Full Text] [Related]
30. [Treatment of Graves' ophthalmopathy with oral or intravenous corticosteroids].
Brauer VF; Scholz GH
Med Klin (Munich); 2004 Feb; 99(2):71-6. PubMed ID: 14963657
[TBL] [Abstract][Full Text] [Related]
31. Orbital cobalt radiotherapy and systemic or retrobulbar corticosteroids for Graves' ophthalmopathy.
Pinchera A; Marcocci C; Bartalena L; Panicucci M; Marconcini C; Lepri A; Cavallacci G; Cartei F; Laddaga M
Horm Res; 1987; 26(1-4):177-83. PubMed ID: 3596466
[TBL] [Abstract][Full Text] [Related]
32. A long-term follow-up study after retro-orbital irradiation for Graves' ophthalmopathy.
Schaefer U; Hesselmann S; Micke O; Schueller P; Bruns F; Palma C; Willich N
Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):192-7. PubMed ID: 11777638
[TBL] [Abstract][Full Text] [Related]
33. Probable risk of tumour induction after retro-orbital irradiation for Graves' ophthalmopathy.
Snijders-Keilholz A; De Keizer RJ; Goslings BM; Van Dam EW; Jansen JT; Broerse JJ
Radiother Oncol; 1996 Jan; 38(1):69-71. PubMed ID: 8850428
[TBL] [Abstract][Full Text] [Related]
34. The efficacy of radiation therapy in the treatment of Graves' orbitopathy.
Matthiesen C; Thompson JS; Thompson D; Farris B; Wilkes B; Ahmad S; Herman T; Bogardus C
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):117-23. PubMed ID: 21030157
[TBL] [Abstract][Full Text] [Related]
35. Can contrast enhanced MRI predict the response of Graves' ophthalmopathy to orbital radiotherapy?
Ott M; Breiter N; Albrecht CF; Pradier O; Hess CF; Schmidberger H
Br J Radiol; 2002 Jun; 75(894):514-7. PubMed ID: 12124238
[TBL] [Abstract][Full Text] [Related]
36. Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy.
Mourits MP; Prummel MF; Wiersinga WM; Koornneef L
Clin Endocrinol (Oxf); 1997 Jul; 47(1):9-14. PubMed ID: 9302365
[TBL] [Abstract][Full Text] [Related]
37. Advances in treatment of active, moderate-to-severe Graves' ophthalmopathy.
Wiersinga WM
Lancet Diabetes Endocrinol; 2017 Feb; 5(2):134-142. PubMed ID: 27346786
[TBL] [Abstract][Full Text] [Related]
38. Low- versus high-dose radiotherapy for Graves' ophthalmopathy: a randomized, single blind trial.
Kahaly GJ; Rösler HP; Pitz S; Hommel G
J Clin Endocrinol Metab; 2000 Jan; 85(1):102-8. PubMed ID: 10634372
[TBL] [Abstract][Full Text] [Related]
39. Long-term safety of orbital radiotherapy for Graves' ophthalmopathy.
Marcocci C; Bartalena L; Rocchi R; Marinò M; Menconi F; Morabito E; Mazzi B; Mazzeo S; Sartini MS; Nardi M; Cartei F; Cionini L; Pinchera A
J Clin Endocrinol Metab; 2003 Aug; 88(8):3561-6. PubMed ID: 12915636
[TBL] [Abstract][Full Text] [Related]
40. [Treatment of Graves' ophthalmopathy with irradiation].
Slampa P; Spurný V; Seneklová Z; Krákorová D
Vnitr Lek; 1998 Aug; 44(8):461-3. PubMed ID: 10358449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
